[Weekly Compilation of Presidential Documents Volume 31, Number 44 (Monday, November 6, 1995)]
[Page 1966]
[Online from the Government Publishing Office, www.gpo.gov]
<R04>
Statement on Signing Biotechnology Process Patent Legislation
November 1, 1995
I am pleased to sign into law S. 1111, a bill to provide enhanced
protection of biotechnology process patents. This bill will update
current patent law to provide the protection American biotechnology
companies need to continue developing new products. American consumers
will benefit from improvements in the diagnosis, cure, or treatment of
disease and from the production of healthier, more abundant foods.
Process patents are especially important in biotechnology, since
part of the genius of that field is to produce commercial quantities of
breakthrough products through new and inventive processes. If the
innovative process used to make a biotechnology product is not protected
by patent, American biotechnology will remain vulnerable to foreign
imitation. This bill will provide necessary new protection for
processes, spurring innovation and keeping American jobs in America.
In less than two decades, the biotechnology industry has created
more than 100,000 high-wage American jobs and it now generates annual
sales of over $7 billion. Originating in the United States,
biotechnology has already produced life-saving drugs that dissolve blood
clots in heart attack victims and treat anemia in patients suffering
from chronic kidney failure. It has helped produce disease-resistant
plants, more nutritious foods, effective waste treatment systems, and
methods to clean and protect the environment. American companies working
to commercialize breakthrough products should not be required to face
unfair competition from overseas.
This bill addresses the need for current patent laws to keep pace
with the rapid growth in biotechnology. It was passed with the strong
support of this Administration and broad bipartisan support in the
Congress. I am pleased to sign S. 1111 into law to ensure the continued
development of important products for American consumers and continued
U.S. job growth in this field.
William J. Clinton
The White House,
November 1, 1995.
Note: S. 1111, approved November 1, was assigned Public Law No. 104-41.